Azienda Ospedaliero Universitaria Ospedali Riuniti Ancona

Hospital


Location: Ancona, Italy (IT) IT

ISNI: 0000000417596306

ROR: https://ror.org/0213f0637

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party (2021) Hayden PJ, Eikema DJ, De Wreede LC, Koster L, Kroger N, Einsele H, Minnema M, et al. Journal article Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network (2021) Gay F, Guenther A, Offidani M, Engelhardt M, Salvini M, Montefusco V, Patriarca F, et al. Journal article Phenotype and risk factors of venom-induced anaphylaxis: a case-control study of the European Anaphylaxis Registry (2020) Francuzik W, Ruëff F, Bauer A, Bilò MB, Cardona V, Christoff G, Dölle-Bierke S, et al. Journal article Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases (2020) Lynch KD, Chapman RW, Keshav S, Montano-Loza AJ, Mason AL, Kremer A, Vetter M, et al. Journal article Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry (2019) Kraft M, Knop MP, Renaudin JM, Scherer Hofmeier K, Pfoehler C, Bilo MB, Lang R, et al. Journal article Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension (2019) Bringhen S, Milan A, D'Agostino M, Ferri C, Waesch R, Gay F, Larocca A, et al. Journal article Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN) (2018) Larocca A, Dold SM, Zweegman S, Terpos E, Waesch R, D'Agostino M, Scheubeck S, et al. Journal article, Review article International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease (2018) Williamson K, Lytvyak E, Kremer A, De Krijger M, Trivedi P, Estes D, Yu L, et al. Conference contribution Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry (2018) Worm M, Francuzik W, Renaudin JM, Bilo MB, Cardona V, Hofmeier KS, Kohli A, et al. Journal article